SK-Pharma Denies Shortage of Diabetes Medications Amidst Complaints

SK-Pharma disputes claims of shortages in diabetes medications, stating that 95-97% of required drugs are supplied. The company's chairman, Nurlybek Assylbekov, stated that they have detailed data to address concerns raised by a member of the Qazaqstan Khalyk Kenesi.

Read the full article at LS →

Headline and summary written by daryo. The full report belongs to LS.